Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Radiat Biol ; 76(11): 1545-54, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11098857

RESUMO

PURPOSE: To report 18 months of cytogenetic follow-up for an Iranian worker accidentally overexposed to 192Ir, the mathematical extrapolation and comparison with clinical data. MATERIAL AND METHODS: Unstable chromosome aberrations were measured using conventional cytogenetic tests by French and Iranian biological dosimetry laboratories on five occasions after the exposure. The decrease in dicentrics over time was analysed mathematically. In addition, Dolphin and Qdr extrapolations were applied to the data to check the exposure estimates. FISH determination of translocation yields was performed twice by the French laboratory and the results compared with the Dolphin and Qdr corrected values. RESULTS: Dose estimates based on dicentrics decreased from 3.1 +/- 0.4 Gy at 5 days after the accident to 0.8 +/- 0.2 Gy at 529 days. This could be fitted by double-exponential regression with an inflexion point between rapid and slow decrease of dicentrics after about 40 days. Dose estimates of 3.4 +/- 0.4 Gy for the Qdr model and 3.6 +/- 0.5 Gy for the Dolphin model were calculated during the post-exposure period and were remarkably stable. FISH translocation data at 26 and 61 days appeared consistent with the Dolphin and Qdr estimates. CONCLUSION: Dose correction by the Qdr and Dolphin models and translocation scoring appeared consistent with the clinical data and provided better information about the radiation injury than did crude estimates from dicentric scoring alone. Estimation by the Dolphin model of the irradiated fraction of the body seemed unreliable: it correlated better with the fraction of originally irradiated lymphocytes.


Assuntos
Irídio/efeitos adversos , Doenças Profissionais/etiologia , Lesões por Radiação/etiologia , Liberação Nociva de Radioativos/estatística & dados numéricos , Radioisótopos/efeitos adversos , Radiometria/estatística & dados numéricos , Biometria , Aberrações Cromossômicas , Citogenética , Humanos , Hibridização in Situ Fluorescente , Irã (Geográfico) , Masculino , Modelos Teóricos , Doenças Profissionais/sangue , Doenças Profissionais/genética , Exposição Ocupacional , Lesões por Radiação/sangue , Lesões por Radiação/genética , Fatores de Tempo
2.
Mutagenesis ; 15(6): 489-94, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11077000

RESUMO

To evaluate the genetic damage induced by tuberculosis infection and also by a combination of therapeutic exposure to anti-tuberculosis (anti-TB) drugs (isoniazid + rifampicin + pyrazinamide + ethambutol or streptomycin) we have considered chromosome aberrations (CA) and micronuclei (MN) in binucleate peripheral blood lymphocytes from 36 patients diagnosed with pulmonary tuberculosis prior to receiving anti-TB drugs in the first phase and in the second phase after 6 months of therapy with anti-TB drugs. The same cytogenetic study has also been performed on 36 healthy individual controls. It was shown that the frequencies of both CA and micronucleated binucleate cells increased significantly after therapy with anti-TB drugs as compared with TB patients and controls. In addition, we observed that both cytogenetic markers (CA and MN) in patients before treatment with anti-TB drugs were significantly (P: < 0.05) higher than controls. No relationship was found between the frequency of MN and donor age. Thus, apart from drug effects, infection with tuberculosis is associated with increased CA and MN.


Assuntos
Antituberculosos/farmacologia , Aberrações Cromossômicas , Linfócitos/metabolismo , Micronúcleos com Defeito Cromossômico , Adolescente , Adulto , Fatores Etários , Idoso , Antibióticos Antituberculose/farmacologia , Estudos de Casos e Controles , Núcleo Celular/efeitos dos fármacos , Núcleo Celular/metabolismo , Etambutol/farmacologia , Feminino , Humanos , Isoniazida/farmacologia , Linfócitos/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Pirazinamida/farmacologia , Rifampina/farmacologia , Estreptomicina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA